Melanoma

If you have been NEWLY DIAGNOSED  START HERE 

Cancer Journey


VIDEOS

Dr. Rafeh Naqash, one of the participants in the GRACE Patient Education Ambassador Program, shares a fantastic video series on understanding clinical...

Dr. Rafeh Naqash, one of the participants in the GRACE Patient Education Ambassador Program, shares a fantastic video series on understanding clinical...

Dr. Rafeh Naqash, one of the participants in the GRACE Patient Education Ambassador Program, shares a fantastic video series on understanding clinical...

Dr. Rafeh Naqash, one of the participants in the GRACE Patient Education Ambassador Program, shares a fantastic video series on understanding clinical...

Dr. Rafeh Naqash, one of the participants in the GRACE Patient Education Ambassador Program, shares a fantastic video series on understanding clinical...

ARTICLES

From the Grace Archives | Originally Published April 22, 2012 | By Dr West | 12 Comments We know that there is a big difference between a lung (or...
From the Grace Archives | Originally Published October 26, 2011 | By Dr Harman | 14 Comments I consider GRACErs a very enlightened bunch regarding of...

With the plethora of Medicare options available, here is an overview of Medicare terms and options along with things to consider when choosing a...

What are Patient Reported Outcomes and why are they important to patients? Patient reported outcomes (PROs) can be thought of as any report or...

From the Grace Archives | Originally Published May 30, 2011 | By Dr West | 3 Comments In my last post, I described a recent piece in the NEJM that...

COMMUNITY FORUM

RECENT POSTS

2020 MELANOMA - MCKEAN - Combination Immunotherapy vs Monotherapy for Metastatic Melanoma

Video
GRACE is excited to bring you a new series on current updates in Melanoma Treatment

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.   

 
In this video, Dr. McKean discusses combination immunotherapy vs. monotherapy for Metastatic Melanoma.

 

Tulane University online survey - looking for individuals with a cancer diagnosis

Forums
The research team at Tulane University is conducting an online survey of individuals with cancer. 

GRACE has been asked to share information about an anonymous one-time online research study about personality and cancer care. They are looking for adults with a history of cancer. A total number of 2,500 individuals will participate in the study, recruited from various social media platforms and websites dedicated to cancer research and patient support.

 

Possible aggressive skin cancer being misdiagnosed?

Forums

My husband had a scar like white patches start on the back of one hand about 6-7 weeks ago. At first he was told it was a chemical burn and treated. However it began to spread and did not respond to treatment. He was told after that, in order, that it was ringworm, bacterial infection, fungal infection, and treated for all with no response to treatment. The once 8-10 small patches on one hand have become 1 large patch covering the back of both hands, both elbows, and now his ears.

GRACE and Clinical Care Options Online Patient Tool for Ovarian Cancer

Article
Have you received a diagnosis of ovarian cancer?

GRACE is excited to have again partnered with Clinical Care Options to develop an Interactive Decision Support Tool and downloadable resource to help you understand more about your disease and treatment options, so you can become partners with your oncology team in your cancer care. 

Covid-19 Financial Impacts and Resources for the Cancer Patient

Article
Covid-19 Financial Impacts and Resources for the Cancer Patient

As many of you know, the costs of treating a new disease or virus are often astronomical, and most insurance companies are in flux as they incorporate these therapies into their step therapies and tier programs, and work to come up with medical necessity criteria to allow coverage for experimental treatments.